Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.2 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |